Vitro SAB Valuation
| VITROA Stock | MXN 9.00 0.10 1.12% |
At this time, the company appears to be overvalued. Vitro SAB de has a current Real Value of 7.47 per share. The regular price of the company is 9.0. Our model measures the value of Vitro SAB de from inspecting the company fundamentals such as Shares Outstanding of 470.03 M, operating margin of 0.05 %, and Return On Equity of -0.0649 as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Vitro SAB's price fluctuation is not too volatile at this time. Calculation of the real value of Vitro SAB de is based on 3 months time horizon. Increasing Vitro SAB's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Vitro SAB is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Vitro Stock. However, Vitro SAB's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 9.0 | Real 7.47 | Hype 9.0 |
The real value of Vitro Stock, also known as its intrinsic value, is the underlying worth of Vitro SAB de Company, which is reflected in its stock price. It is based on Vitro SAB's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Vitro SAB's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Vitro SAB de helps investors to forecast how Vitro stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Vitro SAB more accurately as focusing exclusively on Vitro SAB's fundamentals will not take into account other important factors: Vitro SAB Total Value Analysis
Vitro SAB de is at this time anticipated to have takeover price of 22.9 B with market capitalization of 9.57 B, debt of 7.22 M, and cash on hands of 149.76 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Vitro SAB fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
22.9 B | 9.57 B | 7.22 M | 149.76 M |
Vitro SAB Investor Information
About 79.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 0.43. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Vitro SAB de has Price/Earnings (P/E) ratio of 271.65. The entity recorded a loss per share of 3.76. The firm last dividend was issued on the 23rd of November 2022. Based on the measurements of operating efficiency obtained from Vitro SAB's historical financial statements, Vitro SAB de is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Vitro SAB Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Vitro SAB has an asset utilization ratio of 77.09 percent. This suggests that the Company is making 0.77 for each dollar of assets. An increasing asset utilization means that Vitro SAB de is more efficient with each dollar of assets it utilizes for everyday operations.Vitro SAB Ownership Allocation
Vitro SAB de shows a total of 470.03 Million outstanding shares. Vitro SAB de has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 78.69 % of Vitro SAB outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Vitro SAB Profitability Analysis
The company reported the revenue of 1.96 B. Net Loss for the year was (106.6 M) with profit before overhead, payroll, taxes, and interest of 437.77 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Vitro SAB's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Vitro SAB and how it compares across the competition.
About Vitro SAB Valuation
The stock valuation mechanism determines Vitro SAB's current worth on a weekly basis. Our valuation model uses a comparative analysis of Vitro SAB. We calculate exposure to Vitro SAB's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Vitro SAB's related companies.V., through its subsidiaries, manufactures, processes, distributes, and sells a range of glass products worldwide. V. was founded in 1909 and is headquartered in San Pedro Garza Garca, Mexico. VITRO SAB operates under Specialty Chemicals classification in Mexico and is traded on Mexico Stock Exchange. It employs 14556 people.
8 Steps to conduct Vitro SAB's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Vitro SAB's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Vitro SAB's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Vitro SAB's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Vitro SAB's revenue streams: Identify Vitro SAB's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Vitro SAB's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Vitro SAB's growth potential: Evaluate Vitro SAB's management, business model, and growth potential.
- Determine Vitro SAB's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Vitro SAB's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Vitro Stock analysis
When running Vitro SAB's price analysis, check to measure Vitro SAB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vitro SAB is operating at the current time. Most of Vitro SAB's value examination focuses on studying past and present price action to predict the probability of Vitro SAB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vitro SAB's price. Additionally, you may evaluate how the addition of Vitro SAB to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |